v3 Template
A

Apellis Pharmaceuticals

Pharmaceuticals/Healthcare WALTHAM, Mass. ~320 employees
Founded
--
Employees (Est.)
~320
16 leaders known
Total Funding
$1.7B
Funding Rounds
5
Last Funding
2025-07-01

About Apellis Pharmaceuticals

Apellis Pharmaceuticals is a company focused on leading the way in complement science to develop life-changing medicines for patients with debilitating diseases. Their mission combines courageous science with compassion, aiming to transform treatment across a broad range of conditions.

Products & Services

Products:Specific products are not detailed in the content, but the company has a dedicated section for 'Our Products' indicating offerings in the pharmaceutical space.
Pipeline:Apellis is working on a pipeline of treatments targeting debilitating diseases driven by complement science.

Specialties

Complement Science Geographic Atrophy Rare Disease Ophthalmology Clinical Trials Research

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Royalty Purchase Agreement
T: -
FT: Royalty Purchase Agreement
A: 300000000
MR: -
FA: up to $300 million
FAN: 300000000
D: 2025-07-01
FD: 2025-07-01
1 investors
2 RT: Debt
T: -
FT: Debt
A: 375000000
MR: -
FA: $375 million
FAN: 375000000
D: 2024-05-14
FD: 2024-05-14
1 investors
3 RT: Public Offering
T: -
FT: Public Offering
A: 402500000
MR: -
FA: approximately $402.5 million
FAN: 402500000
D: 2023-02-27
FD: 2023-02-27
5 investors
4 RT: Public Offering
T: -
FT: Public Offering
A: 350000000
MR: -
FA: approximately $350 million
FAN: 350000000
D: 2023-02-22
FD: 2023-02-22
5 investors
5 RT: Public Offering
T: -
FT: Public Offering
A: 300000000
MR: -
FA: $300 million
FAN: 300000000
D: 2023-02-22
FD: 2023-02-22
5 investors
Royalty Purchase Agreement Latest
2025-07-01
$300.0M
1 investor (Pro only)
Debt 2024-05-14
$375.0M
Public Offering 2023-02-27
$402.5M

View 4 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

G

Gerald Chan

Chairman

S

Sinclair Dunlop

Director

S

Stephanie Monaghan O'Brien

Director

P

Paul Fonteyne

Director

C

Cedric Francois

Co-Founder & Chief Executive Officer/President

A

Alec Machiels

Co-Founder

View 13 more team members with Pro

Unlock Full Team Directory

Recent News

Apellis Pharmaceuticals Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Pharmaceuticals/Healthcare
Company Size
~320 employees (est.)
Locations
WALTHAM, Mass.
Waltham, Mass.
Waltham, Mass. and Stockholm +1 more

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro